Project TAURIEL-Studie – PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY,…

Basic data

Acronym:
TAURIEL-Studie
Title:
PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY, AND SAFETY STUDY OF MTAU9937A IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER`S DISEASE
Duration:
15/10/2018 to 14/09/2022
Abstract / short description:
Placebo-Kontrollierte Studie mit einem Antikörper gegen das Tau-Protein bei Alzheimer-Patienten in einem frühen Krankheitsstadium.
Keywords:
psychiatry
Psychiatrie
Alzheimer-Demenz
Tau-Antikörper

Staff

Project managers

Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Epileptology
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine

Funders

Neu-Isenburg, Hessen, Germany
Help

will be deleted permanently. This cannot be undone.